Latest drug prices and trends for NDC 65862-0777

Subscribe to access the full database, or Try for Free
Drug Name	NDC	Price/Unit ($)	Unit	Date
TRI-MILI 28 TABLET	65862-0777-28	0.13969	EACH	2025-03-19
TRI-MILI 28 TABLET	65862-0777-85	0.13969	EACH	2025-03-19
TRI-MILI 28 TABLET	65862-0777-28	0.12837	EACH	2025-02-19
TRI-MILI 28 TABLET	65862-0777-85	0.12837	EACH	2025-02-19
TRI-MILI 28 TABLET	65862-0777-28	0.12209	EACH	2025-01-22
TRI-MILI 28 TABLET	65862-0777-85	0.12209	EACH	2025-01-22
TRI-MILI 28 TABLET	65862-0777-28	0.12315	EACH	2024-12-18
>Drug Name	>NDC	>Price/Unit ($)	>Unit	>Date

Subscribe to access the full database, or Try for Free

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Drug Name	Vendor	NDC	Count	Price ($)	Price/Unit ($)	Dates	Price Type
No data available in table
>Drug Name	>Vendor	>NDC	>Count	>Price ($)	>Price/Unit ($)	>Dates	>Price Type

The pharmaceutical industry is constantly evolving, with market dynamics and regulatory changes shaping the landscape of drug pricing and availability. In this comprehensive analysis, we'll delve into the market trends and price projections for the National Drug Code (NDC) 65862-0777, a product manufactured by Aurobindo Pharma Limited. Understanding these factors is crucial for healthcare providers, payers, and patients alike as we navigate the complex world of pharmaceutical economics.

Understanding NDC 65862-0777

NDC 65862-0777 is associated with a drug produced by Aurobindo Pharma Limited, a prominent player in the global pharmaceutical market[9]. While the specific drug name is not provided in the search results, we can analyze general trends and factors that influence pricing for similar products in the market.

The Significance of National Drug Codes

National Drug Codes play a pivotal role in the identification and tracking of pharmaceutical products. The FDA's NDC Directory contains vital information about finished drug products, unfinished drugs, and compounded drug products[5]. This unique identifier is crucial for:

Accurate billing and reimbursement
Regulatory compliance
Supply chain management
Market analysis and pricing strategies

Current Market Landscape

The pharmaceutical market is experiencing significant growth and transformation. As we look towards 2025, several key trends are shaping the industry:

Market Size and Growth Projections

The U.S. pharmaceutical market is on a trajectory of substantial growth:

Projected to reach $1.28 trillion by 2030
Compound Annual Growth Rate (CAGR) of 5.36%
Driven by increased production capacity and R&D investments[4]

Emerging Trends in Pharmaceutical Development

Biosimilars expansion
GLP-1 drugs for diabetes and weight loss
Breakthrough therapies and combination formulations
Increased focus on personalized medicine[3]

"Health care within the US is entering a transformative period. Medical spending is projected to reach $485 billion in 2025, according to IQVIA."[3]

Factors Influencing Price Projections

To accurately project the pricing for NDC 65862-0777, we must consider a multitude of factors that influence pharmaceutical pricing:

Regulatory Environment

The regulatory landscape plays a significant role in drug pricing:

Medicare Drug Price Negotiation Program
Potential policy changes with the new administration in 2025
FDA guidelines and approval processes[2]

Competition and Market Demand

The level of competition and market demand can significantly impact pricing:

Presence of generics or biosimilars
Unique therapeutic benefits of the drug
Patient population size and treatment alternatives[4]

Manufacturing and R&D Costs

The costs associated with drug development and production are crucial factors:

Investments in research and clinical trials
Manufacturing processes and quality control
Supply chain management and distribution[3]

Pricing Mechanisms for NDC 65862-0777

Understanding the pricing mechanisms is essential for projecting future costs:

Average Manufacturer Price (AMP) and Unit Rebate Amount (URA)

For drugs covered under the Medicaid Drug Rebate Program:

AMP represents the average price paid by wholesalers
URA is the rebate amount per unit
340B ceiling price = (AMP - URA) × Package Size × Case Pack Size[4]

Example Calculation

Let's consider a hypothetical scenario for NDC 65862-0777:

AMP: $100 per unit
URA: $20 per unit
Package Size: 10 units
Case Pack Size: 5 packages

340B Ceiling Price = (100 - 20) × 10 × 5 = $4,000

This calculation provides a baseline, but actual market prices can vary based on numerous factors[4].

Market Analysis for NDC 65862-0777

To provide a comprehensive market analysis for NDC 65862-0777, we need to consider several key aspects:

Historical Pricing Data

While specific historical data for NDC 65862-0777 is not provided in the search results, analyzing past pricing trends for similar drugs can offer valuable insights into potential future movements.

Competitive Landscape

Understanding the competitive environment is crucial:

Identify direct competitors in the same therapeutic class
Analyze pricing strategies of similar drugs
Assess the potential for new market entrants, including generics or biosimilars

Therapeutic Area Growth

The growth potential of the therapeutic area that NDC 65862-0777 belongs to can significantly impact its pricing and market position. For instance, if it's part of the immunology and inflammation (I&I) sector:

The global immunology market is projected to grow from $103.18 billion in 2024 to $257.39 billion by 2032
CAGR of 12.1% during the forecast period
U.S. immunology market expected to reach $131.25 billion by 2032[8]

Technological Advancements Impacting Pricing

Technological innovations are reshaping the pharmaceutical industry and influencing pricing strategies:

Artificial Intelligence in Drug Development

AI is streamlining various aspects of drug development:

Accelerating drug discovery processes
Optimizing clinical trial designs
Improving manufacturing efficiency

These advancements can potentially reduce development costs, which may influence pricing strategies for drugs like NDC 65862-0777[3].

Precision Medicine and Personalized Therapies

The shift towards precision medicine is changing the pricing landscape:

Targeted therapies may command premium prices
Smaller patient populations for specific genetic profiles
Potential for improved efficacy and reduced overall healthcare costs

Policy and Regulatory Considerations

As we look towards 2025, potential policy changes could significantly impact drug pricing:

Medicare Drug Price Negotiations

The Medicare Drug Price Negotiation Program is set to expand:

15 additional drugs selected for price talks in 2025
Negotiated prices for the second round to take effect in 2027
Potential savings of 40% to 80% compared to list prices[2]

Potential Policy Changes in 2025

With a new administration entering office in 2025, there may be shifts in healthcare policies:

Potential expansion of Medicare coverage to weight loss drugs
Changes in drug pricing regulations
Modifications to the Affordable Care Act

"So much of the health care world now sees obesity as a disease itself. And that is what drove our decision making, that it is the role of Medicare and Medicaid to cover the health services that people need," - Chiquita Brooks-LaSure, Centers for Medicare and Medicaid Services Administrator[2]

Market Demand and Patient Access

The interplay between market demand and patient access is crucial for pricing projections:

Insurance Coverage and Reimbursement

Payer negotiations and formulary placement
Out-of-pocket costs for patients
Potential for value-based pricing models

Patient Assistance Programs

Manufacturer-sponsored programs to improve access
Impact on overall pricing strategy and market share

Supply Chain Considerations

The pharmaceutical supply chain plays a significant role in pricing:

Raw Material Costs

Fluctuations in active pharmaceutical ingredient (API) prices
Impact of global events on supply chain stability

Distribution Channels

Wholesaler and pharmacy markup
Direct-to-consumer models and their impact on pricing

Future Market Scenarios for NDC 65862-0777

Based on the analyzed trends and factors, we can project several potential scenarios for NDC 65862-0777:

Scenario 1: Stable Pricing with Moderate Growth

Gradual increase in price aligned with inflation
Maintained market share due to consistent demand
Limited impact from new market entrants

Scenario 2: Price Pressure from Increased Competition

Introduction of generics or biosimilars
Downward pressure on pricing
Potential for loss of market share

Scenario 3: Premium Pricing for Innovative Formulation

Significant therapeutic advantages over existing treatments
Justification for higher pricing based on improved outcomes
Strong market demand despite premium price point

Strategies for Stakeholders

Given the complex landscape surrounding NDC 65862-0777, various stakeholders should consider the following strategies:

For Manufacturers

Invest in real-world evidence to demonstrate value
Develop patient assistance programs to ensure access
Explore innovative pricing models, such as outcomes-based contracts

For Payers

Conduct thorough cost-effectiveness analyses
Negotiate value-based agreements with manufacturers
Implement utilization management strategies to ensure appropriate use

For Healthcare Providers

Stay informed about therapeutic alternatives and their cost-effectiveness
Advocate for patients to ensure access to necessary treatments
Participate in shared decision-making with patients regarding treatment options

For Patients

Research available assistance programs
Engage in discussions with healthcare providers about treatment costs and alternatives
Consider joining patient advocacy groups for support and information

Key Takeaways

The pharmaceutical market is projected to reach $1.28 trillion by 2030, with a CAGR of 5.36%.
NDC 65862-0777, manufactured by Aurobindo Pharma Limited, is subject to various market forces that will influence its pricing in 2025 and beyond.
Regulatory changes, including Medicare drug price negotiations, will play a significant role in shaping the pricing landscape.
Technological advancements, particularly in AI and precision medicine, are expected to impact drug development costs and pricing strategies.
The immunology and inflammation sector is experiencing robust growth, which may influence pricing if NDC 65862-0777 falls within this therapeutic area.
Stakeholders should prepare for multiple scenarios, ranging from stable pricing to increased competition or premium positioning based on therapeutic value.
Patient access and affordability will remain critical considerations in pricing strategies and market success.

FAQs

Q: How does the National Drug Code (NDC) system impact drug pricing? A: The NDC system plays a crucial role in drug pricing by providing a unique identifier for each drug product. This facilitates accurate billing, reimbursement, and market analysis, which in turn influences pricing strategies and regulatory oversight.
Q: What are the main factors that could influence the price of NDC 65862-0777 in 2025? A: Key factors include regulatory changes, market competition, manufacturing costs, technological advancements in drug development, and overall market demand for the therapeutic class to which NDC 65862-0777 belongs.
Q: How might the Medicare Drug Price Negotiation Program affect drugs like NDC 65862-0777? A: The program could potentially lead to lower prices for drugs selected for negotiation. While it's unclear if NDC 65862-0777 will be directly affected, the program's expansion may create broader market pressure for competitive pricing.
Q: What role does artificial intelligence play in pharmaceutical pricing? A: AI is increasingly used to streamline drug discovery and development processes, potentially reducing R&D costs. This could influence pricing strategies by allowing manufacturers to maintain profitability at lower price points or invest in more innovative therapies.
Q: How can patients and healthcare providers prepare for potential price changes in drugs like NDC 65862-0777? A: Patients and providers should stay informed about therapeutic alternatives, explore patient assistance programs, and engage in open discussions about treatment costs and options. Additionally, they should monitor policy changes that may affect drug pricing and access.

Sources cited: [2] https://www.cbsnews.com/news/medicare-drug-prices-ozempic-wegovy-cost-negotiations/ [3] https://www.pharmacytimes.com/view/managing-sustainable-drug-spend-5-trends-reshaping-pharmacy-benefits-in-2025 [4] https://www.drugpatentwatch.com/p/drug-price/ndc/83634-0776 [5] https://www.fda.gov/drugs/drug-approvals-and-databases/national-drug-code-directory [8] https://www.labiotech.eu/in-depth/biotech-trends-2025/ [9] https://www.findacode.com/ndc/labelers/Aurobindo_Pharma_Limited